Appointment of Dr. Carrie Wolinetz as Associate Director for Science Policy, NIH
February 2, 2015
I am pleased to announce the appointment of Carrie Wolinetz, Ph.D., as the new Associate Director for Science Policy, NIH. This appointment is effective February 23, 2015.
Dr. Wolinetz has most recently been serving as Deputy Vice President for Federal Relations with the Association of American Universities (AAU). Her primary responsibility was to coordinate advocacy on funding and policy issues relating to the National Institutes of Health and biomedical research.
Outside of AAU, Dr. Wolinetz serves as current President of United for Medical Research, a leading coalition of universities, patient groups, and private sector companies advocating for sustainable funding for the National Institutes of Health. In addition, she is an Adjunct Assistant Professor at Georgetown University in the School of Foreign Service’s program on Science, Technology & International Affairs, as well as past Chair of the advocacy committee for the Association for Women in Science (AWIS). She has a B.S. in animal science from Cornell University, and she received her Ph.D. in animal science from The Pennsylvania State University, where her area of research was reproductive physiology.
Prior to joining AAU, Dr. Wolinetz served as the Director of Scientific Affairs and Public Relations at the Federation of American Societies for Experimental Biology (FASEB), where she worked on a portfolio of issues that included federal funding of research, the use of animals in research, cloning and stem cells, and biosecurity.
I would like to thank David Shurtleff most sincerely for serving as the Acting Associate Director for Science Policy over the last several months. His wise and gracious leadership kept this critical part of NIH on a steady and effective path.
Please join me in welcoming Carrie to the NIH leadership team, congratulating her on her appointment, and offering her your full support as she begins her work with us.
Francis S. Collins, M.D., Ph.D.